Expanding access to research infrastructure through the Pipeline Accelerator
Applications close on Friday the 30th of October 2026, 5pm (AEST)
👉 Learn more here: https://phenomicsaustralia.org.au/voucher-scheme/
In this round, Microscopy Australia joins the Pipeline Accelerator scheme, alongside Phenomics Australia, TIA, ANSTO’s National Deuteration Facility (NDF) and Bioplatforms Australia.
Together, these partnerships provide seamless access to an expanded portfolio of capabilities and expertise to support translational therapeutic research.
The Pipeline Accelerator is a competitive voucher-style scheme to subsidise the cost of access to Phenomics Australia, TIA, and NDF-supported facilities, with optional additional access to Bioplatforms Australia and Microscopy Australia via supplementary vouchers. To access a supplementary voucher from Bioplatforms Australia or Microscopy Australia, applicants must also apply for a Phenomics Australia, TIA, and/or NDF voucher in the same application.
This scheme supports therapeutic development projects with up to $50,000, with at least 50% matching funding (co-investment) by the applicant.
Applications are now open. Refer to the guidelines for information on eligibility, funding levels, co-investment expectations and the application process. Applications must be submitted online using the application form. The link to the application form can be found in the guidelines document and application template. We strongly recommend developing your application using the provided template, as the online form cannot be saved and retrieved at a later date.
👉 Learn more here: https://phenomicsaustralia.org.au/voucher-scheme/
Through the NCRIS program, we provide seamless access to a network of national research infrastructure to address the medical products challenge in the 2021 National Research Infrastructure Roadmap. We collectively offer academic researchers and SMEs access to a diverse range of Australian translational medical research capabilities, from the molecular basis of health and disease through to clinical trials.
Contact a Phenomics Australia, TIA, Bioplatforms Australia, Microscopy Australia or NDF facility and they will assist you with your application.
For more information
Contact us at contact@australianphenomics.org.au






